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Xenopus tadpoles can fully regenerate all major tissue types following tail amputation. TGF-β signaling plays essential roles in growth, repair,
specification, and differentiation of tissues throughout development and adulthood. We examined the localization of key components of the TGF-
β signaling pathway during regeneration and characterized the effects of loss of TGF-β signaling on multiple regenerative events. Phosphorylated
Smad2 (p-Smad2) is initially restricted to the p63+ basal layer of the regenerative epithelium shortly after amputation, and is later found in
multiple tissue types in the regeneration bud. TGF-β ligands are also upregulated throughout regeneration. Treatment of amputated tails with SB-
431542, a specific and reversible inhibitor of TGF-β signaling, blocks tail regeneration at multiple points. Inhibition of TGF-β signaling
immediately following tail amputation reversibly prevents formation of a wound epithelium over the future regeneration bud. Even brief inhibition
immediately following amputation is sufficient, however, to irreversibly block the establishment of structures and cell types that characterize
regenerating tissue and to prevent the proper activation of BMP and ERK signaling pathways. Inhibition of TGF-β signaling after regeneration has
already commenced blocks cell proliferation in the regeneration bud. These data reveal several spatially and temporally distinct roles for TGF-β
signaling during regeneration: (1) wound epithelium formation, (2) establishment of regeneration bud structures and signaling cascades, and (3)
regulation of cell proliferation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Regeneration; TGF-β; Xenopus; p-Smad2; SB-431542Introduction
The process of epimorphic regeneration involves the re-
placement of damaged, injured, or amputated tissues or struc-
tures with new and functionally equivalent tissues or structures.
The frog Xenopus laevis can at tadpole stages regenerate the
posterior half of its tail following experimental amputation;
all of the complex structures of the tail, including neural tissue,
notochord, vasculature, muscle, connective tissue, and skin
can regenerate completely (Slack et al., 2004). Xenopus
tadpoles provide an excellent model system for regeneration
studies because they develop rapidly (∼3 days after fertiliza-
tion), can be amputated in large numbers with high and
reproducible rates of regeneration, and can be kept in small⁎ Corresponding author.
E-mail address: mwhitman@hms.harvard.edu (M. Whitman).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.12.031and non-circulating volumes, making chemical perturbations
feasible.
The tadpole tail regenerates completely over a period of
about 1–2 weeks. Within about 24–48 h, regenerative structures
can already be clearly observed. Following wound epithelium
formation, a regeneration bud is formed, which contains rege-
nerative neural and notochord tissues as well as a blastema of
undifferentiated mesenchymal cells including at least one stem
cell type, muscle satellite cells (Chen et al., 2006; Slack et al.,
2004). Later, cells in the regeneration bud undergo cell pro-
liferation and differentiation to generate new tissues; for
example, satellite cells in the blastema differentiate into mature
muscle fibers (Chen et al., 2006; Gargioli and Slack, 2004). A
common theme in Xenopus tail regeneration is the re-expression
of genes and re-activation of signaling pathways that are active
in the embryonic tailbud, which acts as a molecular organizer
for posterior structures during development (Beck et al., 2003;
Sugiura et al., 2004). Several signaling cascades, such as the
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patterning and tail regeneration (Beck et al., 2003, 2006). While
these pathways are clearly necessary for regeneration, the
specific events they regulate during the regenerative process
have not been identified. A significant limitation to defining the
role of signaling pathways in regeneration has been the tem-
poral resolution with which pathway inhibition can be achieved;
traditional genetic or transgenic approaches are difficult to re-
gulate on a time scale fine enough to distinguish early steps in
the regenerative process.
TGF-β signaling is essential for numerous processes of
growth, repair, specification, and differentiation. Canonical
TGF-β as well as activin/nodal-like ligands bind to two serine-
threonine kinase receptors, designated Type I and Type II,
resulting in the phosphorylation of the Type I receptor by the
Type II receptor. This leads to phosphorylation of the signal
transducer Smad2/3, which then translocates to the nucleus and
interacts with transcription factors to regulate downstream gene
expression (Shi and Massague, 2003; Whitman, 1998). The
Type I receptors which are responsible for mediating TGF-β
signaling, as distinct from BMP signaling, are Alk4, Alk5, and
Alk7 (Carcamo et al., 1994; Ryden et al., 1996).
A chemical inhibitor of the TGF-β signaling pathway, SB-
431542, rapidly, specifically, and potently inhibits Alk4/5/7 but
not other related receptors such as BMP receptors (Inman et al.,
2002). We have previously reported that SB-431542 functions
specifically and reversibly in Xenopus and zebrafish embryos
to inhibit Alk4/5/7 in vivo (Ho et al., 2006). Upon treatment
with SB-431542, both developmental phenotype and Smad2
phosphorylation are severely disrupted, phenocopying muta-
tions in TGF-β signaling components; these defects can be
fully rescued by introduction of inhibitor-insensitive Alk4,
demonstrating that SB-431542 acts specifically to block the
TGF-β signaling pathway during embryogenesis (Ho et al.,
2006). The use of this highly specific and well-characterized
TGF-β inhibitor provides a number of advantages over more
traditional genetic manipulations: (a) it is easily applied to
large numbers of tadpoles with highly reproducible effects, (b)
it can be added and removed at specific time points, allowing
for the individual dissection of multiple TGF-β-dependent
events within complex processes such as regeneration, and
(c) it sidesteps the problem of early developmental defects or
lethality.
Since TGF-β signals are active during normal tail develop-
ment (Kondaiah et al., 2000; D.M.H. and M.W., unpublished),
we examined the localization of components of the TGF-β
signaling pathway during tail regeneration in Xenopus tadpoles
and found that phosphorylated Smad2 (p-Smad2) as well as
TGF-β ligands were present throughout regeneration. At a
macroscopic level, inhibition of TGF-β signaling causes failure
of tail regeneration at several timepoints after amputation. On a
cellular level, we have determined that TGF-β signaling has
distinct roles in wound epidermis formation, establishment of
regenerative structures, and cell proliferation. We also found
that TGF-β signaling is required for the proper activation of
BMP and ERK signaling pathways in the regeneration bud.
These results reveal that the activation of the TGF-β signalingpathway is essential at multiple timepoints for establishing and
maintaining regenerative competence.
Materials and methods
Regeneration experiments
All regeneration experiments were performed on Xenopus tadpoles at stages
40–43 (Nieuwkoop and Faber, 1967). Tadpoles were anesthetized in Tricaine
(Sigma) and the posterior third to half of the tail was cut off using a micro-
feather scalpel. All regenerates were grown at 20 °C in 0.1×MMRwith 50 units/
ml penicillin/streptomycin (Invitrogen). SB-431542 (Tocris) was used at a final
concentration of 100 μM (50 mM stock in DMSO), taking into account tadpole
volume; SB-431542 was always premixed with the media to ensure
solubilization. SB-505124 (Sigma) and LY-364947 (Sigma) were used at
25 μM and 100 μM, respectively, from stocks in DMSO. Nocodazole (Sigma)
and hydroxyurea (Sigma) were used at 10 μg/ml and 30 mM respectively. For
experiments in which SB-431542 or nocodazole was washed out, tadpoles were
thoroughly rinsed off at least twice in large volumes of clean media. 0.2%
DMSO was used throughout as a control.
For biotinylation experiments, live tadpoles were treated with 1 mg/ml
sulfo-NHS-LC-biotin (Pierce) for 5′ at room temperature, followed by two
brief rinses and two 5′ washes in 100 mM Tris, pH 7.6, to quench unbound
biotin.
For BrdU incorporation assay, regenerates were treated with inhibitor for 6 h
prior to BrdU addition. BrdU (Roche) was then added to a final concentration of
0.2 mM.
Antibodies
Anti-p-Smad2 polyclonal antibody (Faure et al., 2000) was used at 1:10–
1:100. Monoclonal antibody to p63 (clone 4A4) was used at 1:50 (Yang et al.,
1998). Monoclonal antibodies to Xen1 and Pax7 were used at 1:25. Tor70
monoclonal antibody was used at 1:20. Anti-p-Smad1 polyclonal antibody
(Cell Signaling Technology) was used at 1:100, anti-phospho-Histone H3
polyclonal (Upstate) was used at 1:400, and anti-pERK1/2 monoclonal (Clone
MAPK-YT, Sigma) was used at 1:200. HRP-conjugated secondary antibodies
(Jackson ImmunoResearch) were used at 1:750. Secondary antibodies con-
jugated to AlexaFluor 488 or AlexaFluor 546 (Molecular Probes) were used at
1:500.
Staining and in situ hybridization
Samples for whole-mount immunostaining and in situ hybridization were
fixed in MEMFA. Fixative for anti-p-Smad2 samples was supplemented with
5 mM iodoacetamide (Sigma). Standard protocols were used for immunostain-
ing (Faure et al., 2000). HRP activity was detected using TrueBlue substrate
(KLP). Biotinylation was detected using streptavidin-AlexaFluor 546 (1:500,
Molecular Probes). Total DNAwas labeled using TO-PRO-3 (Molecular Probes)
or Hoechst (Molecular Probes).
A standard protocol for whole-mount in situ hybridization was used
(Harland, 1991), with modifications as suggested byM. Levin. Antisense probes
for xTGFβ2 and xTGFβ5 were obtained from I. Dawid (Kondaiah et al., 2000;
Rebbert et al., 1990).
Samples for hematoxylin and eosin (H&E) staining were fixed in MEMFA,
dehydrated in ethanol, embedded in Paraplast, and sectioned to 10 μm thickness.
H&E staining was performed using a basic protocol by Roza Vazin (http://
tropicalis.berkeley.edu/home/gene_expression/sections/H%26E-protocol.html).
BrdU detection was performed using a modified protocol and reagents from
the BrdU Labeling and Detection kit II (Roche).
Microscopy
All confocal microscopy was performed on a Nikon TE2000 microscope
with C1 confocal. Light microscopy was performed using Leica MZFLIII and
Leica DMIRB microscopes.
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Phospho-Smad2 is upregulated throughout regeneration with
changing localization
We used an antibody specific for phosphorylated Smad2 (p-
Smad2) (Faure et al., 2000; Lee et al., 2001) for whole-mountFig. 1. Timecourse of phospho-Smad2 activation during tail regeneration. (A) p-Smad
(B) 4 hpa and 2 dpa regenerates treated with 100 μM SB-431542 at 0 hpa and 24 hpa
treated regenerates are discussed later in this work (see Fig. 4). Arrowheads: amput
amputation. A higher-magnification view of the boxed region of each image is showimmunostaining on regenerating tadpole tails to examine the
activation of the TGF-β signaling pathway during regeneration.
We find that p-Smad2 is upregulated throughout regeneration
and is localized differentially at early and late timepoints. A
freshly amputated tail (0 hpa) has no detectable p-Smad2 stain-
ing; however, nuclear p-Smad2 is present within 1 h post-
amputation (1 hpa) at the edges of the amputation site, where it2 staining of regenerates harvested at 0, 1, 2, 4, 8, and 24 hpa, and at 2 and 3 dpa
, respectively, show no p-Smad2 staining. Phenotypic differences in SB-431542-
ation plane. (C) Regenerates stained for p-Smad2 at 0′, 15′, 30′, and 1 h post-
n below it. Arrows point to representative p-Smad2-positive nuclei.
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Smad2 appears restricted to a single layer near the edge of the
amputation site (Fig. 1A). At 24 hpa, Smad2 phosphorylation is
more widespread, and it extends throughout the entire regene-
ration bud region by 48–72 hpa (Fig. 1A). A closer examination
of very early timepoints reveals weak activation of p-Smad2 near
the outer edges of the amputated fin as early as 15 min
after amputation; this signal has extended medially by 30 min
(Fig. 1C).
Regenerates treated with the TGF-β inhibitor SB-431542 do
not show any staining, indicating that the nuclear signal we
observe with the anti-p-Smad2 antibody is indeed specific (Fig.
1B). We often observe staining around the edges of the somite;
this signal is non-specific, as it is non-nuclear and insensitive to
SB-431542 (Fig. 1B and data not shown).
We also detect p-Smad3, an additional SB-431542-sensitive
transducer of Alk4/5/7 signaling downstream of TGF-β, byFig. 2. Localization of phospho-Smad2 staining. (A) Regenerates treated with 0.2%
stained with anti-p-Smad2 (green) and anti-p63 (red). DNA is stained in blue. A high
overlap between p-Smad2 and p63 at 4 hpa but not at 24 hpa. White arrow marks a
epidermal cell that does not express p-Smad2. (B) Low power confocal section of the
arrowhead) do not express p-Smad2. (C) 3 dpa regenerates, treated with 0.2% DMS
Tyrosine (pTyr, red), and DNA (blue). Arrow: apical epithelial cell; arrowhead: basaWestern blot (data not shown). Since p-Smad2 and p-Smad3 are
coordinately regulated by Alk4/5/7 signaling, and available
antibodies cannot reliably detect p-Smad3 by immunohisto-
chemistry, we have focused on p-Smad2 as a marker of TGF-β
signal activation during regeneration.
To identify the specific cell types in which p-Smad2 is
present, we performed double immunofluorescence staining
and confocal imaging on early (4 hpa), intermediate (24 hpa),
and late (3 dpa) regenerates. At 4 hpa, all nuclei positive for p-
Smad2 in the regeneration bud are also positive for the
transcription factor p63 (white arrow, Fig. 2A). p63 is a marker
of the basal layer of the Xenopus epidermis (Lu et al., 2001). P-
Smad2 is restricted to p63+ nuclei; notably, the apical layer of
the skin (pink arrow, Fig. 2A) expresses neither p-Smad2 nor
p63. P-Smad2 is only expressed in the newly formed wound
epidermis of the regeneration bud; p63+ cells elsewhere in the
tail do not express p-Smad2 (Fig. 2B, white arrowhead). AsDMSO or 100 μM SB-431542 at 0 hpa and fixed at 4 or 24 hpa were double
-power confocal section through the regeneration bud area is shown. Note total
representative nucleus in the p-Smad2+/p63+ layer. Pink arrow marks an apical
DMSO-treated regenerate in panel A, showing that p63+ cells in the fin (white
O or 100 μM SB-431542 at 2 dpa, were stained for p-Smad2 (green), phospho-
l epithelial cell; bl: blastema; nt: neural tube; not: notochord. Scale bar: 50 μm.
Table 1
Wound healing phenotype in 8 hpa regenerates treated at 0 hpa
Healed Unhealed # of experiments
100 μM SB-431542
at 0 hpa
0/123 (0%) 123/123 (100%) 3
0.2% DMSO at 0 hpa 107/107 (100%) 0/107 (0%) 3
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Smad2 even in p63+ cells (Fig. 2A). By 24 hpa, p-Smad2 is no
longer restricted to cells expressing p63 (Fig. 2A).
At 3 dpa, p-Smad2 is detected in all cells in the regeneration
bud. Double staining for p-Smad2 and phospho-Tyrosine (pTyr,
which labels cell boundaries) reveals that p-Smad2-positive
nuclei are found in multiple cell types, including the blastema,
neural ampulla, regenerating notochord, and both layers of the
epidermis (Fig. 2C).
TGF-β ligands are expressed in regenerating tails
RT-PCR analysis reveals that both xTGF-β2 and xTGF-β5,
the two known TGF-β ligands in Xenopus, are present in uncut
tails and upregulated during regeneration (Fig. S1). Whole-
mount in situ hybridization shows that xTGF-β2 message is
first detected very weakly at 4 hpa, in the center of the
regeneration bud, and expression continues there, growing
stronger as regeneration proceeds (Fig. 3A). This transcript
appears to be localized to the mesenchyme in the regeneration
bud region and is excluded from the overlying epidermal layer
(Fig. 3B). In contrast, xTGF-β5 expression is seen as early as
2 hpa, where it is located along the ventral edge of the
regeneration bud (Fig. 3C). By 24 hpa, it is found along the
dorsal edge as well; expression continues along both edges
through at least 72 hpa (Fig. 3C). Like xTGF-β2, xTGF-β5 is in
the regeneration bud proper, beneath the skin (Fig. 3D).
RT-PCR also shows that the TGF-β family members
xActivinβA and xGDF11 are both upregulated at early (4 hpa)
and late (48 hpa) timepoints (Fig. S1). The Alk5 homolog xTrR-I
was present in both cut and uncut tails (data not shown).Fig. 3. Expression pattern of TGF-β ligands during tail regeneration. (A) Whole-mo
0 hpa, 4 hpa, 8 hpa, 24 hpa, 2 dpa, and 3 dpa. Red arrows point to xTGF-β2 expres
magnification of the 24 hpa tail from panel A, showing xTGF-β2 expression (red a
arrow). (C) Whole-mount in situ hybridization with xTGF-β5 antisense probe on rege
of xTGF-β5 (red arrows) as early as 2 hpa. (D) Phase contrast image at higher magn
arrows) in the regeneration bud proper but not in the overlying epithelium (black arPhenotypic effect of inhibition of TGF-β signaling during
regeneration
To further examine the role of TGF-β signaling during
regeneration, we used SB-431542 to block p-Smad2 during
specific time periods post-amputation. Treatment with SB-
431542 immediately following amputation resulted in a failure
of the wound to heal properly. 100% of DMSO-treated controls
had a clearly defined wound epidermis and protruding regene-
ration bud by 8 hpa (n=107; Table 1 and Fig. 4A). In contrast,
all amputated tadpoles treated with SB-431542 at 0 hpa failed to
form a wound epidermis; accordingly, no regeneration bud was
formed and cellular material began to leak from the wound in
100% of treated tadpoles (n=123; Table 1 and Fig. 4A). This
leakage was not caused by failure to form a blood clot, as both
control and SB-treated tadpoles rapidly stop bleeding (Fig. 4A
and data not shown).
Treatment with SB-431542 at later timepoints post-amputa-
tion halts regeneration at the time of application. 86% of control
tadpoles show full regeneration by 6 dpa, with new muscle,
vasculature, neural tube, notochord, and fin in evidence (n=36;
Table 2 and Fig. 4B, left panel). In contrast, only 4% of tadpoles
treated with SB-431542 at 3 dpa had an equivalent amount of
regenerated tissue; the other 96% display a reduced amountunt in situ hybridization with xTGF-β2 antisense probe on regenerating tails at
sion (blue staining) in the regeneration bud. (B) Phase-contrast image at higher
rrow) in the regeneration bud proper and not in the overlying epithelium (black
nerating tails at 0 hpa, 2 hpa, 4 hpa, 24 hpa, 2 dpa, and 3 dpa, showing expression
ification of the 2 dpa sample from panel C, showing xTGF-β5 expression (red
row). Arrowheads: amputation plane.
Fig. 4. Inhibition of TGF-β signaling perturbs tail regeneration. (A) Amputated
tadpoles were treated with 100 μM SB-431542 (bottom row) or 0.2% DMSO
(top row) at 0 hpa, and photographed at 0 and 8 hpa. Note that an epithelial layer
has formed in the DMSO control (arrow), but not in the SB-treated tail, where
cellular material leaks from the wound (arrowhead). Tadpoles were stained in
vivo with Nile Blue to improve resolution. (B) Regenerates were treated with
100 μM SB-431542 at 3 dpa and photographed at 6 dpa. Arrowheads mark the
plane of amputation. (C) Regenerates were treated with 100 μM SB-431542
from 0 to 8 hpa and photographed at 6 dpa. Compare to the DMSO control in
panel B. Arrow: healed epithelium.
Table 2
Phenotype of 6 dpa regenerates treated from 3 to 6 dpa
Full
regeneration
Short
regeneration a
# of
experiments
100 μM SB-431542 at 3–6 dpa 2/45 (4%) 43/45 (96%) 3
25 μM SB-505124 at 3–6 dpa 0/21 (0%) 21/21 (100%) 2
0.2% DMSO at 3–6 dpa 31/36 (86%) 5/36 (14%) 3
Only those tadpoles showing good regeneration at 3 dpa were used for this
experiment.
a Short regenerates are between one-half to two-thirds the length of full
regenerates, or approximately the length of a 3 dpa regenerate.
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6 dpa, comparable to that seen in a 3 dpa regenerate (n=45;
Table 2 and Fig. 4B, right panel). Treatment with a different
TGF-β inhibitor, SB-505124 (DaCosta Byfield et al., 2004),
generated a similar result (0% full length, 100% short length,
n=21; Table 2). A third inhibitor, LY-364947(Sawyer et al.,
2003), also yielded the same phenotype (data not shown).
Finally, we examined the effect of a short window of inhi-
bition of TGF-β signaling on the regeneration phenotype.
Treatment of amputated tadpoles from 0–8 hpa was sufficient to
permanently block regeneration: very little to no regeneration
was observed at 6 dpa (0% regenerated fully, 79% unregener-
ated, n=97; Table 3 and Fig. 4C) in contrast to the DMSO
control (87% regenerated fully, 1% unregenerated, n=75; Table
3 and Fig. 4B). SB-505124-treatment over the same window
resulted in an identical phenotype (0% regenerated fully, 75%
unregenerated, n=69; Table 3), as did LY-364947 treatment
(data not shown). In a minority of inhibitor-treated cases (19%
for SB-431542, 23% for SB-505124; Table 3), a very small
spike containing no recognizable structures was present; thisspike was never seen in controls (Table 3). Interestingly, these
tadpoles do have a complete epithelium over the amputation site
(arrow in Fig. 4C), suggesting that the SB-431542-induced
block to epithelial healing is reversible. P-Smad2 signaling
recovers within 4 h of SB-431542 removal, confirming inhibitor
reversibility (data not shown).
Inhibition of TGF-β signaling reversibly blocks wound
epithelium formation
We used confocal microscopy to examine bilayered wound
epidermis formation following amputation. p63 was used to
mark the basal epidermal layer (green); the apical layer was
labeled with non-cell permeant Sulfo-NHS-LC-biotin (red). In
the control, a full bilayered epithelium forms within 8 h after
amputation (Fig. 5A, top row). Interestingly, the p63+ basal
layer forms first, within 2 hpa; the apical layer does not com-
pletely form until 8 hpa (Fig. 5A, top row). Epithelial healing
appears to result from cell migration rather than proliferation, as
very few mitotic nuclei are observed and healing is nocodazole-
insensitive (data not shown). In contrast, amputated tadpoles
treated at 0 hpa with SB-431542 do not form either the basal or
the apical epithelial layer over the future regeneration bud,
although the edges of the fins do heal (Fig. 5A, bottom row).
Tadpoles pre-treated with SB-431542 prior to amputation still
displayed the same pattern of healing (data not shown),
indicating that the differential effects on regeneration bud and
fin healing are not caused by failure of the inhibitor to act
quickly enough.
The effect of SB-431542 on wound epidermis formation is
reversible. Amputated tadpoles treated with SB-431542 from
0–8 hpa and then recovered in inhibitor-free media display a
bilayered wound epidermis by 24 hpa and later (Fig. 5B and
data not shown). The area below the new epidermis, however,
appears flatter compared to controls at 2 dpa (Fig. 5B),
suggesting that a proper regeneration bud has not formed.
Furthermore, the epithelium in control but not SB-431542-
treated regenerates tends to become thicker by 2 dpa (arrow),
likely representing regeneration of fin tissue (Fig. 5B).
A brief, early inhibition of TGF-β signaling prevents
establishment of regenerative structures
Although the effect of a short, early inhibition of TGF-β
on wound epidermis formation is reversible (Fig. 5B), these
Table 3
Phenotype of 6 dpa regenerates treated from 0 to 8 hpa
Full
regeneration
Partial
regeneration a
Spike b No regeneration # of experiments
100 μM SB-431542 at 0–8 hpa 0/97 (0%) 2/97 (2%) 18/97 (19%) 77/97 (79%) 3
25 μM SB-505124 at 0–8 hpa 0/69 (0%) 1/69 (1%) 16/69 (23%) 52/69 (75%) 4
0.2% DMSO at 0–8 hpa 65/75 (87%) 9/75 (12%) 0/75 (0%) 1/75 (1%) 4
a Partial regenerates contain some but not all recognizable structures and are considerably smaller than full regenerates.
b Spikes do not contain any recognizable structures and are much smaller than regenerates.
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examined regeneration bud structures such as the neural
ampulla, notochord tip, and blastema in 2 dpa amputated tad-
poles that had been treated from 0 to 8 hpa with SB-431542.
Hematoxylin and eosin (H&E) staining of a sagittal section
through the regeneration bud region reveals that the neural tube
in SB-431542-treated tadpoles fails to form a hollow, rounded
terminal ampulla (Fig. 6A). This result is confirmed by staining
with the neural antibody Xen1, which also reveals that the cut
end of the neural tube in the SB-431542-treated tail is distorted
and disorganized (Fig. 6B). Treatment with SB-505124 and LY-
364947 also resulted in similar phenotype of the neural tube
(data not shown).Fig. 5. Inhibition of p-Smad2 signaling reversibly prevents formation of an epithelia
with 1 mg/ml sulfo-NHS-LC-biotin before amputation. (A) Regenerates were treated
and stained with streptavidin (red, apical epithelial layer) and anti-p63 (green, basal ep
showing normal epithelial healing. (B) Inhibition of epithelial healing is reversible. Re
harvested at 2 dpa, and stained as above. Arrow: thickened epithelium seen at 2 dpaSimilarly, the densely packed mass of cells normally found at
the caudal end of the cut notochord is not observed by H&E
staining in an amputated tadpole treated with SB-431542 from
0–8 hpa (Fig. 6A). Staining with the antibody Tor70, which
recognizes immature (regenerating) but not mature notochord
cells, shows a severe reduction in size of the regenerating
notochord as well as a failure to form the characteristic bullet-
shaped notochord tip (arrows, Fig. 6C).
The number of mesenchymal blastema cells observed by
H&E staining at 2 dpa in the SB-431542-treated (0–8 h) rege-
neration bud appears severely diminished compared to the
control (Fig. 6A). We therefore stained these samples for Pax7,
a marker of satellite cells, which are resident in the blastema atl layer over the amputation site. The apical layer of the tadpole skin was labeled
with 100 μM SB-431542 or 0.2% DMSO at 0 hpa, fixed at 0, 1, 2, 4, and 8 hpa,
ithelial layer). Arrow: medial area showing no epithelial healing; arrowhead: fin
generates were treated with 100 μMSB-431542 or 0.2% DMSO from 0 to 8 hpa,
in the control but not the SB-431542-treated tadpole. Scale bar: 100 μm.
Fig. 6. Early SB-431542 treatment blocks formation of regenerative structures at
2 dpa. Regenerates were treated from 0–8 hpa with 100 μM SB-431542 or 0.2%
DMSO and harvested at 2 dpa. (A) H&E staining of sagittal sections (B) Xen-1
(neural tissue) staining (C) Tor70 (regenerating notochord) staining (D) double
staining for Pax7 (red, muscle satellite cells) and DNA (blue). nt: neural tube,
not: notochord, bl: blastema, sc: satellite cells. Arrowheads: amputation plane.
Scale bar: 100 μm.
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the SB-431542-treated tail (Fig. 6D), indicating failure of
satellite cells to populate the regeneration bud.
The SB-431542 treatment did not cause increased apoptosis,
as assessed by activated caspase-3 immunostaining, either
immediately following treatment (8 hpa) or at 2 dpa (Fig. S2).
Additionally, nocodazole-treated embryos still developed a re-
generation bud, indicating that this early SB-431542 phenotype
does not result from a block to proliferation (data not shown).
Taken together with the phenotype analysis, these data show
that a short, early inhibition (from 0 to 8 hpa) of p-Smad2signaling is sufficient to block the later appearance of
regenerative structures. Even though certain effects of TGF-β
inhibition (wound epidermis formation) are reversible, regen-
erative capacity, as assessed by the presence of neural, noto-
chord, and muscle precursors, is permanently lost.
Early TGF-β signal inhibition prevents activation of BMP and
ERK signaling pathways in the regeneration bud
Previous studies suggest that BMP and ERK (Extracellular
Signal-related Kinase) signaling pathways are essential for
establishment and/or maintenance of regeneration bud struc-
tures in Xenopus (Beck et al., 2006; Suzuki et al., 2007).
Therefore, we asked whether early SB-431542 treatment would
affect the activation of BMP and ERK in regenerating tails.
Amputated tadpoles treated with SB-431542 or DMSO
control from 0–8 hpa were examined at 2 dpa for the presence
of BMP pathway components. Immunostaining for phospho-
Smad1 (p-Smad1), the direct intracellular activator of BMP
signaling, showed that control regenerates showed high levels
of p-Smad1 in the regeneration bud, especially in the blastema,
the regenerating fin, and the dorsal side of the neural ampulla
(Fig. 7A). In contrast, SB-431542-treated tadpoles did not
display any p-Smad1 in the regeneration bud region (Fig. 7A).
This reduction in p-Smad1 staining in the regeneration bud is
not caused by direct, non-specific inhibition of BMP receptors
by SB-431542, since p-Smad1 in stage-matched, unamputated
tadpole tails was unaffected by this treatment (Fig. 7A).
We also examined expression of the transcription factor
Msx1, a known target of BMP signaling that is upregulated in
virtually all regenerating systems (Stoick-Cooper et al., 2007).
In situ hybridization for xMsx1 shows that Msx1 expression in
the dorsal blastema of 2 dpa regenerates is abolished in tadpoles
treated with SB-431542 from 0 to 8 hpa (Fig. 7B), consistent
with the lack of p-Smad1 in these tadpoles.
Beck et al. (2006) have shown that regenerates transgenic for
the BMP inhibitor noggin demonstrate reduced proliferation in
the regeneration bud. Therefore, we examined cellular prolif-
eration by staining for the mitotic marker phospho-Histone H3
(pH3). We find that the increased proliferation normally seen in
the regeneration bud by 2 dpa is absent in SB-431542-treated
tails (Fig. 7C). Taken together, these data indicate that TGF-β
signaling very early in the regenerative process is required
upstream of BMP signaling and its dependent processes in the
regeneration bud.
We have also examined the role of ERK signaling
downstream of TGF-β in tail regeneration, as it is implicated
in both wound healing and regeneration and is downstream of
FGFs (Christen and Slack, 1999; Poss et al., 2000; Suzuki et al.,
2007). Staining for diphosphorylated ERK1/2 (pERK1/2) in
regenerating tails shows that pERK1/2 activation at 8 hpa is
primarily in the wound epithelium, consistent with a role in
wound healing, but shifts to a largely blastemal pattern by 2 dpa
(Fig. 8). Interestingly, this blastemal pERK1/2 component is
never seen in amputated tadpoles treated from 0 to 8 hpa with
SB-431542 (Fig. 8B). Instead, these treated tadpoles often
display a continued expression of pERK1/2 in all or part of the
Fig. 7. Early inhibition of TGF-β signaling prevents subsequent activation of the BMP signaling pathway in the regeneration bud. Regenerates treated with 100 μM
SB-431542 or 0.2% DMSO from 0 to 8 hpa were harvested at 2 dpa and processed for the following markers: (A) immunofluorescence against phospho-Smad1
(p-Smad1, green), showing that p-Smad1 in the regeneration bud proper is eliminated by SB-431542 treatment. p-Smad1 (blue) in unamputated stage-matched
tadpole tails was unaffected by SB-431542 (bottom row); (B) in situ hybridization with xMsx1 antisense probe (purple)—black arrow: xMsx1 expression in the
dorsal blastema; (C) immunofluorescence for the mitotic marker phospho-Histone H3 (pH3, green). Total DNA in panels A and C is shown in blue. Arrowheads:
amputation plane. Scale bar: 100 μM.
Fig. 8. Early inhibition of TGF-β signaling results in aberrant pERK1/2 activation in the regeneration bud. Immunofluorescence staining for phospho-ERK1/2 (red)
and total DNA (blue). (A) 8 hpa untreated regenerates, showing pERK1/2 staining primarily in the wound epithelium (orange arrow). (B) 2 dpa regenerates, treated
with 100 μM SB-431542 or 0.2% DMSO from 0 to 8 hpa. White arrow: blastemal p-ERK1/2 in controls. Green arrow: aberrant pERK1/2 in the epithelium of SB-
431542-treated tadpoles. Arrowheads: amputation plane. Scale bar: 100 μM.
211D.M. Ho, M. Whitman / Developmental Biology 315 (2008) 203–216
212 D.M. Ho, M. Whitman / Developmental Biology 315 (2008) 203–216wound epithelium, although in some cases no expression at all
is seen (Fig. 8B and data not shown).
TGF-β-dependent cell proliferation specifically in the
regeneration bud
Tadpoles in which TGF-β signaling was blocked only after
the establishment of a regeneration bud (at 3 dpa) still stop
regenerating (Fig. 4B). High levels of proliferation are normally
observed in the regeneration bud starting at about 2 dpa (Beck
et al., 2006; D.M.H and M.W., unpublished). We therefore
examined the effect of late TGF-β inhibition on cellular
proliferation by immunostaining for pH3, which revealed that
regenerates treated with SB-431542 at 2 dpa have greatly
reduced proliferation in the regeneration bud at 3 dpa (Fig. 9A).
We quantitated the number of pH3+ cells in a 2000 μm2 area of
the regeneration bud, fin, and somite anterior to the amputationFig. 9. Effect of late TGF-β inhibition on proliferation in the regeneration bud. (A) Ph
431542 or 0.2% DMSO at 2 dpa and harvested at 3 dpa for immunofluorescence for a
3 dpa regenerates treated as in panel A. Numbers of pH3+ nuclei in a 2000 μm2 area
each sample, a similarly located area was selected. n=7 for DMSO and 6 for SB, ex
from 3 separate experiments, except for fins (2 experiments). Error bars: ±1 SD. *p=
for 9 h total, including final 3 h with nocodazole (NOC) arrest, and stained at 3 dpa fo
BrdU incorporation assay. Regenerates were treated with 100 μM SB-431542 or 0.2%
initiation of SB-431542 treatment. BrdU+ nuclei are labeled in red and total DNA in b
arrow) but not rostral to the level of the amputation plane (orange arrow); in contrast, t
BrdU incorporation. Similarly, proliferation in the fin (green arrow) is not affected. W
arrow: fin in regeneration bud. Scale bar: 100 μm. Arrowheads: amputation plane.site. This analysis showed that the number of mitotic nuclei was
significantly increased (approximately four-fold) in the regen-
eration bud compared to surrounding tissues, and that this
increase was completely abolished with SB-431542 treatment
(p=0.00005, Fig. 9B). SB-431542 treatment had no effect on
numbers of mitotic nuclei in the fin or somite (Fig. 9B). In
order to more clearly determine which cells in the regeneration
bud were affected, nocodazole was used to “trap” dividing
cells, effectively allowing us to visualize by pH3 staining all of
the cells that have divided in a 3 h time window. This analysis
showed that proliferation in the neural tube, notochord, and
blastema at 3 dpa was all reduced by SB-431542 treatment
(Fig. 9C).
Similarly, a BrdU incorporation assay shows that, over a
longer time window of 2–4 dpa, very few cells in the
regeneration bud of SB-treated tadpoles have divided, whereas
almost all of the cells in the control have incorporated BrdUospho-Histone H3 (pH3) expression. Regenerates were treated with 100 μM SB-
nti-pH3 (green). Total DNA is shown in blue. (B) Quantitation of pH3+ nuclei in
of a confocal section were counted in the regeneration bud, fin, and somite. For
cept for fin samples, where n=5 for both DMSO and SB. Samples were drawn
0.00005. (C) Regenerates were treated with 100 μM SB-431542 or 0.2% DMSO
r pH3 (green) and DNA (blue). nt: neural tube, not: notochord, bl: blastema. (D)
DMSO at 2 dpa and harvested at 4 dpa. BrdU was added to the media 6 h after
lue. BrdU incorporation in the control is increased at the regeneration bud (white
he SB-431542-treated tail does not show any obvious rostro-caudal differences in
hite arrow: regeneration bud; orange arrow: tail rostral to amputation plane; green
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the plane of amputation remain at a low baseline level in both
treated and untreated cases (orange arrows in Fig. 9D, top row).
BrdU incorporation in the fin and epidermis surrounding the
regeneration bud also does not seem to be affected by SB-
431542 (green arrows in Fig. 9D, lower panels). Taken together,
these data indicate that TGF-β signaling stimulates cell division
only in the regeneration bud proper but not in outlying tissues.
Treatment of regenerates at 3 dpa with the cell cycle inhibitor
hydroxyurea or nocodazole results in a very similar phenotype
to SB-431542 treatment (Fig. S3). Direct proliferation inhibi-
tion results in a reversible regeneration block, as regenerates
treated with nocodazole from 3–4 dpa can recover and begin to
regenerate once again after nocodazole removal (Fig. S3). In
contrast, regenerates treated during the same time window with
SB-431542 are unable to maintain a regenerative state and
regeneration does not recommence (Fig. S3), despite recovery
of p-Smad2 signaling shortly after inhibitor removal (data not
shown).
Discussion
Rapid and sustained activation of the TGF-β signaling
pathway in regeneration
We have combined spatial analysis using a p-Smad2-specific
antibody with temporal analysis using the chemical inhibitor
SB-431542 to elucidate multiple distinct roles for TGF-β
signaling during regeneration. The TGF-β signaling pathway is
rapidly activated and remains on throughout regeneration; p-
Smad2 is observed as early as 15 min post-amputation (Fig. 1).
To the best of our knowledge, this is earliest reported molecular
event in regeneration.
Activation of αvβ6 integrin by mechanical stimulation at
wounds and other sites of epithelial remodeling is a rapid,
highly localized mechanism for the activation of ECM-bound
latent TGF-β protein (Breuss et al., 1995; Munger et al., 1999;
Sheppard, 2005). This mechanism provides the most plausible
explanation for the rapidly appearing Smad2 phosphorylation in
the basal epidermal layer. Additionally, in mammalian studies,
platelets and macrophages can migrate to wound sites and
release TGF-β (Assoian and Sporn, 1986; Assoian et al., 1987;
Blakytny et al., 2004). Although the role of platelets and
macrophages has not been studied in Xenopus, blood clotting
occurs within minutes following amputation; this blood clot and
its associated molecules may have a significant early role in the
regenerative process. Finally, although the literature suggests
that activation of latent TGF-β is the most likely candidate for
an early, localized signal, we cannot rule out the involvement of
other family members, such as activin.
Inhibition of TGF-β signaling blocks the following events:
(1) formation of a wound epithelium over the amputation site,
(2) establishment of regenerative structures, (3) proper activa-
tion and localization of BMP and ERK signaling pathways, and
(4) cell proliferation in the regeneration bud. Interestingly,
inhibition of BMP signaling does not affect early events such as
epithelial healing or neural ampulla formation, but only blockslater events such as proliferation (Beck et al., 2006). In contrast,
our data show that a sustained level of p-Smad2 is required for
both establishment and maintenance of regeneration and that
TGF-β signaling is upstream of BMP and ERK signaling
pathways, suggesting that TGF-β activation may be one of the
first crucial and defining events of the regenerative pathway.
Notably, recent work in zebrafish has shown that ActivinβA is
important for cell migration and proliferation in regenerating
zebrafish tail fins (Jazwinska et al., 2007), indicating that a
crucial role for TGF-β signals is conserved between multiple
regenerative systems.
Spatial regulation of p-Smad2 activation
p-Smad2 expression is initially restricted to a single cell type
(the basal layer of the wound epidermis) in the regeneration
bud, and only later does its expression become widespread. The
mechanism for this differential regulation of signal activation is
unclear. One hypothesis is that only the p63+ basal epidermal
layer is exposed to active TGF-β ligand. This possibility is
consistent with the activation of TGF-β by αvβ6 integrin,
which requires direct cell-to-cell contact and results in ex-
tremely localized signaling (Munger et al., 1999; Sheppard,
2005). Another possibility is that only p63+ cells have the
capacity to respond to TGF-β during the early stages of rege-
neration. Examination of positive and negative regulators of
TGF-β signaling at the amputation site will be an interesting
area for future study.
In contrast to the highly localized activation of p-Smad2
immediately post-amputation, the later broad distribution of p-
Smad2 suggests a freely diffusible ligand that activates
signaling in an unrestricted, concentration-dependent manner.
Thus, the early restriction must be lifted from 24 hpa onward,
perhaps by widespread activation of the necessary signaling
components and/or downregulation of repressors in previously
unresponsive cells. The change from early, regulated p-Smad2
to later, widespread signaling may represent a molecular switch
between two broad stages of regeneration: an early stage char-
acterized by cellular migration and establishment of regenera-
tive structures and a late stage characterized by cellular pro-
liferation and differentiation of new tissues.
Epithelial–mesenchymal interactions in the regeneration bud
TGF-β signaling stimulates the formation of a wound
epidermis following amputation, which is required, but not in
itself sufficient, for tail regeneration. A second signaling event
between the epidermis and the underlying mesenchyme appears
to be necessary to initiate the regeneration program and
establish a regeneration bud. TGF-β may be needed simply
for formation of the epithelium, which can then participate in an
additional, TGF-β-independent inductive event. We do not
favor this hypothesis because p-Smad2 signaling remains high
even after epithelial healing is complete. Alternatively, TGF-β
may be directly or indirectly involved in an inductive event.
During the period of regenerative competency, p-Smad2 is
present specifically in the basal layer of the wound epithelium
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underlying tissue (Fig. 3). One possible scenario is that ligand
produced in the putative regeneration bud region would
stimulate the TGF-β signaling pathway in the basal epithelial
layer, which in turn would send a second signal back to the
mesenchyme, thus enabling the activation of a regenerative
pathway. In the absence of this type of signaling mechanism
following amputation and epithelial healing, a simple “wound
healing” pathway would prevail, resulting in loss of regen-
erative competence.
FGFs may provide this epithelial-to-mesenchymal signal.
FGF-20 has been implicated in blastema formation in zebrafish
fin regeneration (Whitehead et al., 2005); FGF-8 is produced by
the apical ectodermal ridge (AER), an epithelial structure in the
developing limb which signals to and patterns the underlying
mesenchyme, and is expressed in regenerating Xenopus tails
and limbs (Beck et al., 2006; Mahmood et al., 1995).
Furthermore, FGFs signal through the ERK pathway, which is
activated in the regeneration bud in a TGF-β-dependent manner
(Fig. 8).
TGF-β signaling and cellular proliferation during regeneration
In this work, we report that TGF-β signaling drives a
localized proliferation response in the regeneration bud proper,
but does not affect cell division in adjacent tissues (Fig. 9).
Although TGF-β is generally considered anti-proliferative, it
can stimulate proliferation in certain cell types or under certain
conditions (Ruscetti et al., 2005; Seoane, 2006). Jazwinska et al.
(2007) have also recently shown that activin can promote
proliferation in zebrafish fin blastema, indicating that TGF-β
signals can induce proliferation in multiple regenerative
systems. TGF-β may promote proliferation through its effects
on BMP and/or ERK signaling, as inhibition of either of these
pathways has been shown to reduce proliferation in regenerative
structures (Beck et al., 2006; Poss et al., 2000).
p63 and regeneration
The tight localization of p-Smad2 to the p63+ layer of the
epidermis during early regeneration is particularly striking. p63
is expressed at high levels in the basal, progenitor layers of
many types of epithelia, and may play a role in the maintenance
or commitment of an epithelial stem cell population (Yang et al.,
1999). p63 null mice fail to form an AER, resulting in severely
diminished FGF-8 production and ultimately truncated limbs
missing various structures (Mills et al., 1999; Yang et al., 1999).
By analogy, the p63+ layer over the amputation site may act as
an organizing, AER-like structure that directs the early tissue
interactions and epithelial–mesenchymal signaling events
required to establish a regeneration bud. It will be interesting
in the future to examine the effect of loss of p63 function on
regenerative phenotypes in Xenopus tadpoles and other model
systems.
In our experiments, the p63+ layer always forms first over the
wound site, while migration of the second, outer layer is
somewhat delayed. We have observed the same phenomenon innon-regenerating situations, such as in the rostral cut surface of
an explanted tail, indicating that the p63+ cell layer may be the
first structure formed during healing of wounds, both regen-
erative and non-regenerative, in Xenopus tadpoles. p63 has been
identified as a key regulator of epithelial adhesion in mammals
(Carroll et al., 2006), and may confer distinctive adhesive
properties that allow rapid wound covering by the basal
epidermal layer in Xenopus tadpoles. Xenopus skin, with its
relatively simple bilayered organization, may therefore serve as
a useful model system for the study of the role of p63 during
wound healing as well as regeneration.
A time window of regenerative competence
The molecular basis for the decision between regeneration
and simple wound healing is central to the problem of
understanding epimorphic regeneration. The ability to establish
a regeneration program is lost after as little as 8 h in SB-431542,
even though restoration of p-Smad2 signaling and formation of
a morphologically normal bilaminar wound epidermis occur
rapidly following SB-431542 removal. This observation
indicates that there is a limited time window following ampu-
tation within which regeneration can commence, and after this
window closes only simple healing is possible. Whether this
represents a change in the wound epidermis itself (e.g. a time-
dependent loss of capacity to produce a regenerative signal), a
change in underlying mesenchymal cells (e.g. a time-dependent
loss of capacity to respond to a signal from the wound epi-
dermis), or some other mechanism will be an interesting area for
further investigation.
Signals regulating wound healing and regeneration
Our work demonstrates that TGF-β signaling is essential
both for initial closure of a wound, and subsequently for the
establishment and maintenance of the regeneration program.
Early events in regeneration are likely to be similar to those in
non-regenerative wound healing; however, downstream events
must then diverge.
What regulates the distinction between wound healing and
regeneration? Our examination of p-ERK1/2 signals during
regeneration suggests the intriguing possibility that a shift in p-
ERK activation from an early, primarily epithelial localization
to a later, primarily blastemal localization (Fig. 8) may underlie
the shift from the initial wound healing phase to the regenerative
phase. Furthermore, the shift in p-ERK activation patterns does
not occur when TGF-β signaling is inhibited early; rather, p-
ERK often remains high in the wound epithelium long after it
normally subsides (Fig. 8), suggesting that in the absence of
TGF-β signaling, a sustained wound healing response prevails
and regeneration is inhibited. Interestingly, experiments in
younger Xenopus embryos showed that developmentally
regulated p-ERK signals were FGF-dependent, whereas p-
ERK induced by wounding was not (Christen and Slack, 1999).
In light of this observation, it will be interesting to examine the
FGF dependence of the two phases of ERK signal activation
during regeneration.
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been implicated both in productive processes such as re-
epithelialization and contractility and in non-productive ones
such as fibrosis (Leask and Abraham, 2004;Werner et al., 2007).
For example, both the rate of wound re-epithelialization and the
degree of scarring were enhanced in mice overexpressing activin
and reduced in those overexpressing follistatin (Munz et al.,
1999; Wankell et al., 2001). Smad3-null mice, intriguingly,
display either enhanced or inhibited wound closure depending
on the type of wound (Arany et al., 2006; Ashcroft et al., 1999).
These and other studies underscore the importance of proper
signal regulation in the choice between a productive, regen-
erative response and a non-productive, fibrotic one.
This distinction is likely to be critical for understanding the
molecular pathways that distinguish regeneration from simple
wound healing. Different cell types and different transcriptional
response programs are likely to lie downstream of signals
common to both wound healing and regeneration. The
combination of specific pharmacological inhibitors such as
SB-431542, techniques that permit labeling of specific cell
populations in vivo (Gargioli and Slack, 2004), and tissue-
specific rescue from inhibition (Ho et al., 2006) will allow
further spatiotemporal resolution of the role of signaling
pathways in specific events during the regenerative process.
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